Emerah Sherif H, Sabry Moataz M, Saad Hisham A, Ghobashy Waleed A
Ophthalmology Department, Research Institute of Ophthalmology, Giza, Egypt.
Magrabi Eye Hospital, Dubai, UAE.
Int J Ophthalmol. 2019 May 18;12(5):840-843. doi: 10.18240/ijo.2019.05.22. eCollection 2019.
We evaluated the visual and refractive outcomes after phakic visian toric implantable collamer lens (ICL) insertion in stable keratoconus (KC). This retrospective study investigated toric ICL implantation in 14 eyes of 8 patients with stable KC. After 6mo, the mean uncorrected distance visual acuity improved significantly from 0.77 to 0.15 logMAR. The mean best corrected distance visual acuity (BCDVA) improved from 0.18±0.1 to 0.15±0.1 logMAR. Fifty percent of eyes maintained their preoperative BCDVA; 42.8% gained one line. There was no statistical difference in high order or coma aberration. The mean refractive manifest spherical equivalent (MSE), mean refractive manifest spherical error, mean manifest astigmatism decreased significantly postoperatively. At 6mo postoperatively, our achieved mean spherical equivalent was approximately 74%. No intraoperative or postoperative complications occurred. Toric ICL implantation was effective, predictable and safe to correct refractive error and improve visual acuity in patients with stable KC.
我们评估了在稳定圆锥角膜(KC)患者中植入有晶状体眼Visian toric可植入式角膜接触镜(ICL)后的视觉和屈光效果。这项回顾性研究调查了8例稳定KC患者的14只眼中的toric ICL植入情况。6个月后,平均未矫正远视力从0.77显著提高至0.15 logMAR。平均最佳矫正远视力(BCDVA)从0.18±0.1提高至0.15±0.1 logMAR。50%的眼睛维持了术前的BCDVA;42.8%的眼睛提高了一行。高阶像差或彗差无统计学差异。术后平均屈光性显验光球镜等效度(MSE)、平均屈光性显验光球镜度数、平均显性散光均显著降低。术后6个月时,我们达到的平均球镜等效度约为74%。未发生术中或术后并发症。toric ICL植入在矫正稳定KC患者的屈光不正和提高视力方面是有效、可预测且安全的。